Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Extension Study of MYL-1701P-3001 for Safety and Efficacy [Phase 3]
Extension study results for MYL-1701P-3001 in diabetic macular edema assessing safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema [Phase 4]
Phase 4 trial comparing dexamethasone implant to intravitreal aflibercept in diabetic macular edema has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]
Phase 3 trial assessing the safety of ONS-5010 in subjects with visual impairment due to retinal disorders completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy [Phase 2]
Phase 2 results for APX3330 in diabetic retinopathy and diabetic macular edema have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME [Phase 3]
Phase 3 trial evaluating the Port Delivery System with ranibizumab versus intravitreal ranibizumab for diabetic macular edema, including a s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema [Phase 1, Phase 2]
A combined Phase 1/2 clinical trial evaluating RO7446603 alone or with aflibercept or faricimab in participants with diabetic macular edema.
-
EMA approval · 2026-04-24EMA Authorised: Ranluspec (ranibizumab) — Lupin Europe GmbH
EMA authorised Ranluspec (ranibizumab) from Lupin Europe GmbH. The product is indicated for several retinal conditions including wet age-rel…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME) [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, pharmacodynamics, and pharmacokinetics of RO7823653 in participants with Diabe…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]
A Phase 3 trial comparing the safety of ONS-5010 when administered from vials versus pre-filled syringes in adults with retinal disorders ca…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) [Phase 1]
Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7497372 in participants with diabetic macular…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial [Phase 4]
A Phase 4 pragmatic, open-label randomized trial compares treat-and-extend versus fixed-dosing regimens of faricimab for diabetic macular ed…
-
CLINICAL_TRIALS other · 2026-04-15Clinical Trial Update: A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema [Phase 2]
A Phase 2 study to test BI 1815368 for diabetic macular edema is currently recruiting.
-
EMA approval · 2026-04-14EMA Authorised: Pavblu (aflibercept) — Amgen Technology (Ireland) UC
EMA has authorised Pavblu (aflibercept) by Amgen Technology (Ireland) UC for multiple ocular indications including wet age-related macular d…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema. [Phase 4]
A Phase 4 post-marketing study assessing the safety and effectiveness of Beovu (brolucizumab) for diabetic macular edema has completed.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.
A Bayer-sponsored clinical trial project in Germany aims to quantify how many patients suffer from major eye diseases and explores new metho…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
A real-world study investigating Faricimab (Vabysmo) for neovascular age-related macular degeneration and diabetic macular edema is currentl…
-
EMA approval · 2026-04-10EMA Authorised: Mynzepli (aflibercept) — Advanz Pharma Limited
The European Union has authorised Mynzepli (aflibercept) from Advanz Pharma Limited for multiple retinal diseases, including wet age-related…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab [NA]
Clinical Trial Update describes an ongoing study evaluating biomarkers in diabetic retinopathy and diabetic macular edema, comparing faricim…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine. [Phase 2]
Phase 2 clinical trial from University of Alabama at Birmingham evaluating an integrative liver-targeted therapy that combines Tauroursodeox…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME [Phase 3]
Phase 3 randomized, double-masked COMO trial is recruiting to compare EYP-1901 with aflibercept for diabetic macular edema.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases
A completed clinical trial compared the treatment burden of intravitreal anti-VEGF therapy across three retinal diseases: age-related macula…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME [Phase 3]
CAPRI is a Phase 3 randomized, double-masked trial assessing the efficacy of EYP-1901 compared with aflibercept in diabetic macular edema; t…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections [Phase 4]
Phase 4 clinical trial evaluating anesthetic options for intravitreal injections. It compares chloroprocaine HCl ophthalmic gel 3% with prop…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema [Phase 3]
Phase 3 clinical trial evaluating BAT5906 compared with Lucentis for diabetic macular edema; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of Avoralstat In Participants With Diabetic Macular Edema [Phase 1]
This update describes a Phase 1 study of Avoralstat in participants with Diabetic Macular Edema, and the trial is currently active but not r…